Status:
UNKNOWN
Anterior Chamber Versus Scleral Fixated Intraocular Lens: Long-term Vision and Safety Outcomes
Lead Sponsor:
Sunnybrook Health Sciences Centre
Conditions:
Corneal Endothelial Cell Loss
Secondary Intraocular Lens
Eligibility:
All Genders
16-99 years
Brief Summary
This is a prospective comparative non-randomized cohort study to understand the long-term vision outcomes, safety, and stability of anterior chamber intraocular lenses (AC IOLs) vs. scleral-fixated in...
Detailed Description
On the pre-operative visit, specular microscopy, biometry, applanation tonometry and ocular coherence tomography (OCT) will be performed. The patient will then undergo treatment as per surgeon's discu...
Eligibility Criteria
Inclusion
- Patients who are undergoing AC IOL or SF IOL implantation for any reason (including but not limited to aphakia, posterior capsular rupture, primary or secondary lens dislocation/ subluxation or IOL exchange).
- Patients on whom imaging (specular microscopy, biometry and OCT) can be performed without delaying their treatment (i.e. based on availability of operator).
- Decision makers able to provide informed consent.
Exclusion
- Inability to obtain adequate imaging, in the form of specular microscopy and OCT data at baseline.
- Patients unable to attend follow-up visits.
- Patients who have had a corneal transplant prior to secondary IOL implantation.
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 30 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04072978
Start Date
September 1 2019
End Date
January 30 2025
Last Update
November 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sunnybrook Hospital
Toronto, Ontario, Canada, M4N 3M5